top of page

News & Media

Get the latest news, events and publications from Helixomer here.

🔬 Advancing RNA Nanotechnology at FNANO 2025

May 8, 2025

🔬 Advancing RNA Nanotechnology at FNANO 2025

🤠 The cowboy’s back on stage—this time at the Seed2Table Showcase!

May 2, 2025

🤠 The cowboy’s back on stage—this time at the Seed2Table Showcase!

Standout Moment at Venture Connect 2025!

April 25, 2025

Standout Moment at Venture Connect 2025!

Helixomer: Pioneering RNA Origami to Revolutionize Safe and Effective Anticoagulation

October 7, 2024

Helixomer: Pioneering RNA Origami to Revolutionize Safe and Effective Anticoagulation

Helixomer on Stage: FNANO 2024

May 17, 2024

Helixomer on Stage: FNANO 2024

Innovative RNA Origami Anticoagulant Research Highlighted at MSE100 Centennial Celebration

May 11, 2024

Innovative RNA Origami Anticoagulant Research Highlighted at MSE100 Centennial Celebration

Helixomer Inc. Secures $2 Million NIH Award for Development of Innovative Intravenous Anticoagulant and Reversal Agent

April 5, 2024

Helixomer Inc. Secures $2 Million NIH Award for Development of Innovative Intravenous Anticoagulant and Reversal Agent

David Harrell Appointed as New President and CEO of Helixomer

April 4, 2024

David Harrell Appointed as New President and CEO of Helixomer

bottom of page